Marian Evatt MD MS
Academic Appointment
- Associate Professor, Department of Neurology, Emory University School of Medicine
Education
Degrees
- MS from Emory University
- MD from Emory University School of Medicine
- BS from Massachusetts Institute of Technology
Research
Focus
- My clinical research focuses on observational and clinical movement disorders trials, including Parkinsons disease, dystonia, and tremor. In particular, I am interested in the epidemiology of nutritional deficits in movement disorders and the potential role of nutritional compounds (vitamin B12, vitamin D) as neuroprotective or symptomatic therapies in movement disorders.
Publications
-
Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study.
Parkinsonism Relat Disord Volume: 104 Page(s): 15 - 20
11/01/2022 Authors: Vaswani PA; Morley JF; Jennings D; Siderowf A; Marek K; PARS investigators -
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up.
Mov Disord Volume: 35 Page(s): 1550 - 1557
09/01/2020 Authors: Siderowf A; Jennings D; Stern M; Seibyl J; Eberly S; Oakes D; Marek K; PARS Investigators -
Rationale and Design of the PAIRED Trial: Partnered Dance Aerobic Exercise as a Neuroprotective, Motor, and Cognitive Intervention in Parkinson's Disease.
Front Neurol Volume: 11 Page(s): 943
01/01/2020 Authors: Hackney ME; Bay AA; Jackson JM; Nocera JR; Krishnamurthy V; Crosson B; Evatt ML; Langley J; Cui X; McKay JL -
Internally Guided Lower Limb Movement Recruits Compensatory Cerebellar Activity in People With Parkinson's Disease.
Front Neurol Volume: 10 Page(s): 537
01/01/2019 Authors: Drucker JH; Sathian K; Crosson B; Krishnamurthy V; McGregor KM; Bozzorg A; Gopinath K; Krishnamurthy LC; Wolf SL; Hart AR -
OUTCOMES OF WEEK-24 COMPLETERS AND SUBJECTS WHO HAD FOLLOW-UP BEYOND WEEK 24 AFTER A SINGLE TREATMENT OF DAXIBOTULINUMTOXINA FOR INJECTION (RT002): RESULTS OF A PHASE 2, OPEN-LABEL (LEVEL II), DOSE-ESCALATING STUDY IN ISOLATED CERVICAL DYSTONIA
Volume: 156 Page(s): S89 - S90
12/01/2018 Authors: Patel AT; Comella CL; Jankovic J; Truong DD; Brashear A; Evatt M; Snyder D; Rubio RG -
Outcomes of Week-24 Completers and Subjects Who Had Follow-Up Beyond Week 24 After a Single Treatment of DaxibotulinumtoxinA for Injection (RT002): Results of a Phase 2, Open-Label (Level II), Dose Escalating Study in Isolated Cervical Dystonia
Volume: 90
04/10/2018 Authors: Jankovic J; Truong D; Patel A; Brashear A; Evatt M; Rubio R; Oh C; Snyder D; Comella C -
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.
Mov Disord Clin Pract Volume: 5 Page(s): 273 - 282
01/01/2018 Authors: Jankovic J; Truong D; Patel AT; Brashear A; Evatt M; Rubio RG; Oh CK; Snyder D; Shears G; Comella C -
SAFETY AND EFFICACY OF DAXIBOTULINUMTOXINA FOR INJECTION (RT002) IN CERVICAL DYSTONIA (CD): RESULTS OF A PHASE 2, DOSE ESCALATING STUDY
Volume: 46 Page(s): E27 - E27
01/01/2018 Authors: Truong D; Comella C; Jankovic J; Brashear A; Patel AT; Evatt M; Oh C; Snyder D; Rubio RG -
A PHASE 2, OPEN-LABEL, DOSE-ESCALATING STUDY TO EVALUATE THE SAFETY AND PRELIMINARY EFFICACY OF DAXIBOTULINUMTOXINA FOR INJECTION (RT002) IN ISOLATED CERVICAL DYSTONIA
Volume: 88
04/18/2017 Authors: Comella C; Brashear A; Jankovic J; Patel A; Truong D; Evatt M; Chung C; Rubio R -
DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient.
Neurol Genet Volume: 2 Page(s): e72
06/01/2016 Authors: Wang L; Maldonado L; Beecham GW; Martin ER; Evatt ML; Ritchie JC; Haines JL; Zabetian CP; Payami H; Pericak-Vance MA